Inside Johnson & Johnson’s Ottava: Engineering the Future of Soft-Tissue Surgical Robotics
Executive Overview Following a landmark FDA de novo authorization, Johnson & Johnson MedTech officially unveiled its next-generation surgical platform, the...
Executive Overview Following a landmark FDA de novo authorization, Johnson & Johnson MedTech officially unveiled its next-generation surgical platform, the...
Executive Overview In a milestone development for computational pathology and cancer diagnostics, an international research team has introduced an advanced...
Executive Overview Long before the first terrestrial footprints scarred the ancient mud, and hundreds of millions of years prior to...
Executive Overview The landscape of modern digital surgery has experienced a profound structural evolution. Following a coveted de novo authorization...